Literature DB >> 30195932

Electrophysiological assessment methodology of sensory processing dysfunction in schizophrenia and dementia of the Alzheimer type.

P Danjou1, G Viardot2, D Maurice2, P Garcés3, E J Wams4, K G Phillips5, V Bertaina-Anglade6, A P McCarthy5, D J Pemberton7.   

Abstract

Schizophrenia and Alzheimer's disease impacts on various sensory processings are extensively reviewed in the present publication. This article describes aspects of a research project whose aim is to delineate the neurobiology that may underlie Social Withdrawal in Alzheimer's disease, Schizophrenia and Major Depression. This is a European-funded IMI 2 project, identified as PRISM (Psychiatric Ratings using Intermediate Stratified Markers). This paper focuses specifically on the selected electrophysiological paradigms chosen based on a comprehensive review of all relevant literature and practical constraints. The choice of the electrophysiological biomarkers were fundamentality based their metrics and capacity to discriminate between populations. The selected electrophysiological paradigms are resting state EEG, auditory mismatch negativity, auditory and visual based oddball paradigms, facial emotion processing ERP's and auditory steady-state response. The primary objective is to study the effect of social withdrawal on various biomarkers and endophenotypes found altered in the target populations. This has never been studied in relationship to social withdrawal, an important component of CNS diseases.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Auditory steady-state potentials; EEG; Electroencephalogram; Emotional processing; Mismatch negativity; Oddball paradigm; Schizophrenia

Mesh:

Substances:

Year:  2018        PMID: 30195932     DOI: 10.1016/j.neubiorev.2018.09.004

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  5 in total

1.  Using Biomarkers to Predict Memantine Effects in Alzheimer's Disease: A Proposal and Proof-Of-Concept Demonstration.

Authors:  Neal R Swerdlow; Juliana E Kotz; Yash B Joshi; Jo Talledo; Joyce Sprock; Juan L Molina; Branko Huisa; Steven F Huege; Jairo Alberto Romero; Michael J Walsh; Lisa Delano-Wood; Gregory A Light
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

2.  Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study.

Authors:  Simon Loiodice; Wilhelmus H Drinkenburg; Abdallah Ahnaou; Andrew McCarthy; Geoffrey Viardot; Emilie Cayre; Bertrand Rion; Valérie Bertaina-Anglade; Marsel Mano; Philippe L'Hostis; Christophe Drieu La Rochelle; Martien J Kas; Philippe Danjou
Journal:  Transl Psychiatry       Date:  2021-04-29       Impact factor: 6.222

3.  Pure Tone Audiometry and Hearing Loss in Alzheimer's Disease: A Meta-Analysis.

Authors:  Susanna S Kwok; Xuan-Mai T Nguyen; Diana D Wu; Raksha A Mudar; Daniel A Llano
Journal:  Front Psychol       Date:  2022-01-21

4.  Abnormality of Functional Connections in the Resting State Brains of Schizophrenics.

Authors:  Yan Zhu; Geng Zhu; Bin Li; Yueqi Yang; Xiaohan Zheng; Qi Xu; Xiaoou Li
Journal:  Front Hum Neurosci       Date:  2022-03-10       Impact factor: 3.169

5.  Greater tau pathology is associated with altered predictive coding.

Authors:  Klevest Gjini; Cameron Casey; Sean Tanabe; Amber Bo; Margaret Parker; Marissa White; David Kunkel; Richard Lennertz; Robert A Pearce; Tobey Betthauser; Bradley T Christian; Sterling C Johnson; Barbara B Bendlin; Robert D Sanders
Journal:  Brain Commun       Date:  2022-08-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.